Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyJohann Bauersachs, Karen Sliwa, Tobias König et al.|European Journal of Heart Failure|2019Cited by 435
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryKaren Sliwa, Johann Bauersachs, Mark C. Petrie et al.|European Heart Journal|2020Cited by 187
Long-Term Prognosis, Subsequent Pregnancy, Contraception and Overall Management of Peripartum Cardiomyopathy: Practical Guidance Paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyKaren Sliwa, Johann Bauersachs, Mark C. Petrie et al.|European Journal of Heart Failure|2018Cited by 146
ACE Inhibitor and Angiotensin Receptor Blocker Use During Pregnancy: Data From the ESC Registry Of Pregnancy and Cardiac Disease (ROPAC)Johanna A van der Zande, Arie Franx, Roger Hall et al.|The American Journal of Cardiology|2024Cited by 9
Pregnancy outcomes in women with heritable thoracic aortic disease: data from the EORP ESC registry of pregnancy and cardiac disease (ROPAC) IIIR Vasallo Peraza, Johanna A van der Zande, Julie De Backer et al.|European Heart Journal - Quality of Care and Clinical Outcomes|2025Cited by 8